Stocks
Change Healthcare Financial Statements (CHNG) |
||||||||||
| Change Healthcaresmart-lab.ru | % | 2022Q4 | 2022Q4 | 2022Q1 | 2022Q2 | 2023Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.03.2022 | 26.05.2022 | 26.05.2022 | 04.08.2022 | 04.08.2022 | 04.08.2022 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 920.1 | 920.1 | 920.1 | 884.5 | 884.5 | 3 609 | |||
| Operating Income, bln rub | 52.8 | 77.3 | 50.8 | 24.4 | 43.0 | 195.5 | ||||
| EBITDA, bln rub | ? | 439.8 | 758.7 | 231.1 | 197.4 | 214.7 | 1 402 | |||
| Net profit, bln rub | ? | 7.09 | -19.5 | 7.09 | -23.2 | -41.8 | -77.4 | |||
| OCF, bln rub | ? | 696.4 | 258.1 | 83.3 | 83.3 | 1 121 | ||||
| CAPEX, bln rub | ? | 276.1 | 83.6 | 79.5 | 79.5 | 518.8 | ||||
| FCF, bln rub | ? | 420.4 | 174.4 | 3.78 | 3.78 | 602.4 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 867.3 | 867.3 | 437.9 | 443.8 | 857.2 | 2 606 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 423.4 | 410.2 | 0.000 | 833.6 | ||||
| R&D, bln rub | 72.3 | 72.3 | 72.3 | 74.2 | 74.2 | 293.0 | ||||
| Interest expenses, bln rub | 57.0 | 57.0 | 57.0 | 56.9 | 56.9 | 227.7 | ||||
| Assets, bln rub | 9 932 | 9 932 | 9 932 | 9 637 | 9 637 | 9 637 | ||||
| Net Assets, bln rub | ? | 3 276 | 3 276 | 3 276 | 3 291 | 3 291 | 3 291 | |||
| Debt, bln rub | 4 664 | 4 664 | 4 664 | 4 560 | 4 560 | 4 560 | ||||
| Cash, bln rub | 252.3 | 252.3 | 252.3 | 94.0 | 94.0 | 94.0 | ||||
| Net debt, bln rub | 4 412 | 4 412 | 4 412 | 4 466 | 4 466 | 4 466 | ||||
| Ordinary share price, rub | 21.8 | 21.8 | 21.8 | 23.1 | 23.1 | 24.8 | ||||
| Number of ordinary shares, mln | 325.0 | 330.8 | 325.0 | 326.6 | 326.6 | 326.6 | ||||
| Market cap, bln rub | 7 085 | 7 212 | 7 085 | 7 531 | 7 531 | 8 086 | ||||
| EV, bln rub | ? | 11 497 | 11 624 | 11 497 | 11 996 | 11 996 | 12 552 | |||
| Book value, bln rub | -4 536 | -4 536 | -4 901 | -4 398 | -4 398 | -4 398 | ||||
| EPS, rub | ? | 0.02 | -0.06 | 0.02 | -0.07 | -0.13 | -0.24 | |||
| FCF/share, rub | 0.00 | 1.27 | 0.54 | 0.01 | 0.01 | 1.84 | ||||
| BV/share, rub | -14.0 | -13.7 | -15.1 | -13.5 | -13.5 | -13.5 | ||||
| EBITDA margin, % | ? | 47.8% | 82.5% | 25.1% | 22.3% | 24.3% | 38.8% | |||
| Net margin, % | ? | 0.77% | -2.12% | 0.77% | -2.62% | -4.72% | -2.14% | |||
| FCF yield, % | ? | 3.47% | 11.3% | 11.5% | 8.00% | 8.00% | 7.45% | |||
| ROE, % | ? | -1.75% | -1.87% | -1.87% | -2.35% | -2.35% | -2.35% | |||
| ROA, % | ? | -0.58% | -0.62% | -0.62% | -0.80% | -0.80% | -0.80% | |||
| P/E | ? | -123.5 | -117.5 | -115.5 | -97.3 | -97.3 | -104.5 | |||
| P/FCF | 8.82 | 40.6 | 1 992 | 12.5 | 13.4 | |||||
| P/S | ? | 2.04 | 2.02 | 1.98 | 2.09 | 2.09 | 2.24 | |||
| P/BV | ? | -1.56 | -1.59 | -1.45 | -1.71 | -1.71 | -1.84 | |||
| EV/EBITDA | ? | 11.2 | 8.42 | 8.33 | 8.56 | 8.56 | 8.95 | |||
| Debt/EBITDA | 4.32 | 3.19 | 3.19 | 3.19 | 3.19 | 3.19 | ||||
| R&D/CAPEX, % | 26.2% | 86.4% | 93.3% | 93.3% | 56.5% | |||||
| CAPEX/Revenue, % | 0.00% | 30.0% | 9.09% | 8.99% | 8.99% | 14.4% | ||||
| Change Healthcare shareholders | ||||||||||
